Trump Institutes Reg Freeze, But Unclear If CMS Must Use Notice And Comment To Delay Final Rules

By Michelle M. Stein / January 23, 2017 at 8:29 PM

The Trump administration instituted a regulatory freeze on Jan. 20 that requires federal agencies not issue any new regulations or guidance documents, pull back any regulations or guidance under review by the Office of the Federal Register, and temporarily postpone regulations and guidance that have been published but have yet to take effect.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.